Sofosbuvir is indicated for use by adults with chronic hepatitis C, meaning infection lasting more than six months. It is approved for people with HCV genotype 1, 2, 3, 4, 5 or 6. Sofosbuvir can be used by people being treated for hepatitis C for the first time (known as 'treatment-naive'). Sofosbuvir can be used by people with all stages of liver disease including compensated and decompensated cirrhosis. However, it works better for people with less advanced liver damage. People with chronic hepatitis C who are awaiting or have received a liver transplant tolerate sofosbuvir better than older medications.

POSSIBLE SIDE EFFECTS OF SOFOSBUVIR:

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.